HIGHLIGHTS
- who: Ruibiao Fu from the Medical College of Qingdao University, China have published the paper: MiR-520a-5p/PPP5C regulation pattern is identified as the key to gemcitabine resistance in pancreatic cancer, in the Journal: (JOURNAL)
- what: At the same time, compared with previous studies on PPP5C and pancreatic cancer, this study examined the expression of miR-520a-5p in pancreatic cancer and its relationship with PPP5C.
- how: After these treatments the cell lines were tested for drug resistance.
- future: This provides a new molecular mechanism for pancreatic cancer research and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.